Correlation Between Revelation Biosciences and Neurosense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Neurosense Therapeutics, you can compare the effects of market volatilities on Revelation Biosciences and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Neurosense Therapeutics.
Diversification Opportunities for Revelation Biosciences and Neurosense Therapeutics
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Revelation and Neurosense is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Neurosense Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Neurosense Therapeutics
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Neurosense Therapeutics. In addition to that, Revelation Biosciences is 3.16 times more volatile than Neurosense Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Neurosense Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 109.00 in Neurosense Therapeutics on November 18, 2024 and sell it today you would earn a total of 7.00 from holding Neurosense Therapeutics or generate 6.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revelation Biosciences vs. Neurosense Therapeutics
Performance |
| Timeline |
| Revelation Biosciences |
| Neurosense Therapeutics |
Revelation Biosciences and Neurosense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Neurosense Therapeutics
The main advantage of trading using opposite Revelation Biosciences and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
| Neurosense Therapeutics vs. Quoin Pharmaceuticals Ltd | Neurosense Therapeutics vs. Revelation Biosciences | Neurosense Therapeutics vs. Virax Biolabs Group | Neurosense Therapeutics vs. Nutriband |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |